VenBio - Xconomy

by in

Entry	Author	Date	Location
VenBio’s Goodman Builds an Inside Periscope on Biotech Acquisitions	Bernadette Tansey	01/23/13	San Francisco
Solstice Biologics Garners $18,000,000 Series A Round	VentureDeal	01/05/13	San Francisco
Labrys Biologics Secures $31,000,000 Series A Funding Round	VentureDeal	01/04/13	San Francisco
San Diego Life Sciences Roundup: Regulus, Aragon, Cytori, & More	Bruce V. Bigelow	10/05/12	San Diego
Aragon Pharmaceuticals Receives $49,999,988 Series D Round	VentureDeal	09/26/12	San Diego
Theraclone’s Cliff Stocks Joins “Reinventing Biotech” Lineup Apr. 3	Luke Timmerman	03/27/12	Seattle
iPierian Shakeup Continues, as Chairman Corey Goodman, Scientist Doug Melton Exit Stem Cell Startup	Luke Timmerman	06/15/11	San Francisco
Will the Bay Area Still Be the No. 1 Biotech Cluster in 20 Years? We’ll Ask Tomorrow	Luke Timmerman	03/15/11	San Francisco
Plexxikon’s Big Payday, InterMune Wins EU Approval, UCSF’s $48M Windfall, & More Bay Area Life Sciences News	Luke Timmerman	03/04/11	San Francisco
Will the Bay Area Lose Its Edge as the Top Biotech Hub in 20 Years? We’ll Ask March 16	Luke Timmerman	03/03/11	San Francisco
California Biotech To Add Jobs, Merck’s Bet on Biotech Drugs in Palo Alto, & More Bay Area Life Sciences News	Luke Timmerman	02/04/11	San Francisco
The 20-Year Outlook for Bay Area Life Sciences, Coming March 16	Luke Timmerman	01/25/11	San Francisco
Page 1 of 1

Xconomy National